26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.

Published

Journal Article (Review)

Full Text

Duke Authors

Cited Authors

  • Cheitlin, MD; Douglas, PS; Parmley, WW

Published Date

  • October 1994

Published In

Volume / Issue

  • 24 / 4

Start / End Page

  • 874 - 880

PubMed ID

  • 7930219

Pubmed Central ID

  • 7930219

International Standard Serial Number (ISSN)

  • 0735-1097

Digital Object Identifier (DOI)

  • 10.1016/0735-1097(94)90843-5

Language

  • eng

Conference Location

  • United States